United Therapeutics (UTHR) Earnings Date, Estimates & Call Transcripts $358.93 -7.46 (-2.04%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends United Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 19Before Market OpensEstimatedActual EPS (Oct. 30) $6.39 Beat By $0.23 Consensus EPS (Oct. 30) $6.16 United Therapeutics released Q3 2024 earnings on October 30, 2024, reporting an EPS of $6.39, which beat analysts' consensus estimates of $6.16 by $0.23. Quarterly revenue rose 22.9% year-over-year to $748.90 million, above analyst estimates of $722.62 million. With a trailing EPS of $22.77 and a P/E Ratio of 15.76, United Therapeutics' earnings are expected to grow 13.68% next year, from $25.22 to $28.67 per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingPowered by UTHR Upcoming EarningsUnited Therapeutics' next earnings date is estimated for Wednesday, February 19, 2025, based off prior year's reporting schedules. Get United Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on United Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataUTHR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.UTHR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. United Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$6.93$6.93$6.93Q2 20251$6.63$6.63$6.63Q3 20251$7.33$7.33$7.33Q4 20251$6.74$6.74$6.74FY 20254$27.63$27.63$27.63Q1 20261$6.42$6.42$6.42Q2 20261$6.47$6.47$6.47Q3 20261$7.15$7.15$7.15 United Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/19/2025(Estimated)-------10/30/2024Q3 2024$6.16$6.39+$0.23$6.39$722.62M$748.90M7/31/2024Q2 2024$6.33$5.85 -$0.48$5.85$691.87M$714.90M5/1/2024Q1 2024$5.63$6.17+$0.54$6.17$620.31M$677.70M2/21/2024Q4 2023$4.28$4.36+$0.08$4.36$575.01M$614.70M11/1/2023Q3 2023$5.10$5.38+$0.28$5.38$585.82M$609.40M8/2/2023Q2 2023$4.57$5.24+$0.67$5.24$524.18M$596.50M5/3/2023Q1 2023$4.26$4.86+$0.60$4.86$514.37M$506.90M2/22/2023Q4 2022$4.12$2.67 -$1.45$2.67$519.20M$491.50M United Therapeutics Earnings - Frequently Asked Questions When is United Therapeutics's earnings date? United Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates. Learn more on UTHR's earnings history. Did United Therapeutics beat their earnings estimates last quarter? In the previous quarter, United Therapeutics (NASDAQ:UTHR) reported $6.39 earnings per share (EPS) to beat the analysts' consensus estimate of $6.16 by $0.23. Learn more on analysts' earnings estimate vs. UTHR's actual earnings. How can I listen to United Therapeutics's earnings conference call? The conference call for United Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read United Therapeutics's conference call transcript? The conference call transcript for United Therapeutics's latest earnings report can be read online. Read Transcript How can I view United Therapeutics's earnings report? United Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $2.33 billion. How much profit does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded net income of $984.80 million. UTHR has generated $22.77 earnings per share over the last four quarters. What is United Therapeutics's price-to-earnings ratio? United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 15.76 and a forward price-to-earnings ratio of 14.23. The price/earnings-to-growth ratio is 0.93. What is United Therapeutics's EPS forecast for next year? United Therapeutics's earnings are expected to grow from $25.22 per share to $28.67 per share in the next year, which is a 13.68% increase. More Earnings Resources from MarketBeat Related Companies ALNY Earnings Results BIIB Earnings Results NBIX Earnings Results INCY Earnings Results BMRN Earnings Results EXAS Earnings Results EXEL Earnings Results RGEN Earnings Results HALO Earnings Results MDGL Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:UTHR) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
